
Sign up to save your podcasts
Or


Episode 8 of the Tread Lightly podcast dives into a popular topic: carbon plated running shoes! If you haven't worn them, you've likely seen the bright neon supershoes at races over the past few years. Carbon plated shoes are hugely popular - but are they the right marathon running shoe for everyone?
In this episode, we discuss:
- Responders vs non-responders to carbon plated running shoes
- Do slower runners get the same benefits?
- Injury risk from carbon plated running shoes
- How to choose the best marathon running shoes for you
More resources:
https://www.runtothefinish.com/marathon-running-shoes/
https://www.runtothefinish.com/nike-zoomx-vaporfly-next-2-review/
https://www.runtothefinish.com/nike-alphafly-vs-vaporfly/
https://lauranorrisrunning.com/marathon-running-shoes/
References
PMID: 36626911
PMID: 34740871
PMID: 35250342
PMID: 34726119
PMID: 36780101
Bhimani et al. (2022). Use of flexible carbon fiber insoles for hallux rigidus: a randomized controlled trial. AOFAS Annual Meeting.
By Amanda Brooks and Laura Norris4.9
356356 ratings
Episode 8 of the Tread Lightly podcast dives into a popular topic: carbon plated running shoes! If you haven't worn them, you've likely seen the bright neon supershoes at races over the past few years. Carbon plated shoes are hugely popular - but are they the right marathon running shoe for everyone?
In this episode, we discuss:
- Responders vs non-responders to carbon plated running shoes
- Do slower runners get the same benefits?
- Injury risk from carbon plated running shoes
- How to choose the best marathon running shoes for you
More resources:
https://www.runtothefinish.com/marathon-running-shoes/
https://www.runtothefinish.com/nike-zoomx-vaporfly-next-2-review/
https://www.runtothefinish.com/nike-alphafly-vs-vaporfly/
https://lauranorrisrunning.com/marathon-running-shoes/
References
PMID: 36626911
PMID: 34740871
PMID: 35250342
PMID: 34726119
PMID: 36780101
Bhimani et al. (2022). Use of flexible carbon fiber insoles for hallux rigidus: a randomized controlled trial. AOFAS Annual Meeting.

1,510 Listeners

1,327 Listeners

858 Listeners

2,046 Listeners

1,343 Listeners

4,098 Listeners

59 Listeners

199 Listeners

202 Listeners

89 Listeners

457 Listeners

296 Listeners

1,769 Listeners

154 Listeners

587 Listeners